• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内在适应 OXPHOS 输出能力和降低的肿瘤发生特性表现在多柔比星耐药的卵巢癌细胞中。

Intrinsic adaptations in OXPHOS power output and reduced tumorigenicity characterize doxorubicin resistant ovarian cancer cells.

机构信息

Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC, United States; East Carolina Diabetes and Obesity Institute, East Carolina University, Greenville, NC, United States.

Human Performance Laboratory, Department of Kinesiology, East Carolina University, Greenville, United States.

出版信息

Biochim Biophys Acta Bioenerg. 2022 Nov 1;1863(8):148915. doi: 10.1016/j.bbabio.2022.148915. Epub 2022 Sep 2.

DOI:10.1016/j.bbabio.2022.148915
PMID:36058252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9661894/
Abstract

Although the development of chemoresistance is multifactorial, active chemotherapeutic efflux driven by upregulations in ATP binding cassette (ABC) transporters are commonplace. Chemotherapeutic efflux pumps, like ABCB1, couple drug efflux to ATP hydrolysis and thus potentially elevate cellular demand for ATP resynthesis. Elevations in both mitochondrial content and cellular respiration are common phenotypes accompanying many models of cancer cell chemoresistance, including those dependent on ABCB1. The present study set out to characterize potential mitochondrial remodeling commensurate with ABCB1-dependent chemoresistance, as well as investigate the impact of ABCB1 activity on mitochondrial respiratory kinetics. To do this, comprehensive bioenergetic phenotyping was performed across ABCB1-dependent chemoresistant cell models and compared to chemosensitive controls. In doxorubicin (DOX) resistant ovarian cancer cells, the combination of both increased mitochondrial content and enhanced respiratory complex I (CI) boosted intrinsic oxidative phosphorylation (OXPHOS) power output. With respect to ABCB1, acute ABCB1 inhibition partially normalized intact basal mitochondrial respiration between chemosensitive and chemoresistant cells, suggesting that active ABCB1 contributes to mitochondrial remodeling in favor of enhanced OXPHOS. Interestingly, while enhanced OXPHOS power output supported ABCB1 drug efflux when DOX was present, in the absence of chemotherapeutic stress, enhanced OXPHOS power output was associated with reduced tumorigenicity.

摘要

尽管化疗耐药性的发展是多因素的,但由 ATP 结合盒(ABC)转运蛋白上调驱动的活性化疗药物外排是很常见的。化疗药物外排泵,如 ABCB1,将药物外排与 ATP 水解偶联,从而可能增加细胞对 ATP 再合成的需求。线粒体含量和细胞呼吸的增加是许多癌症细胞化疗耐药模型的常见表型,包括那些依赖于 ABCB1 的模型。本研究旨在描述与 ABCB1 依赖性化疗耐药相关的潜在线粒体重塑,并研究 ABCB1 活性对线粒体呼吸动力学的影响。为此,在依赖于 ABCB1 的化疗耐药细胞模型中进行了全面的生物能量表型分析,并与化疗敏感对照进行了比较。在多柔比星(DOX)耐药卵巢癌细胞中,线粒体含量增加和呼吸复合物 I(CI)增强同时提高了内在氧化磷酸化(OXPHOS)的功率输出。就 ABCB1 而言,急性 ABCB1 抑制部分使化疗敏感和耐药细胞之间完整的基础线粒体呼吸正常化,这表明活跃的 ABCB1 有助于支持增强的 OXPHOS 的线粒体重塑。有趣的是,虽然当 DOX 存在时增强的 OXPHOS 功率输出支持 ABCB1 药物外排,但在没有化疗应激的情况下,增强的 OXPHOS 功率输出与降低的致瘤性相关。

相似文献

1
Intrinsic adaptations in OXPHOS power output and reduced tumorigenicity characterize doxorubicin resistant ovarian cancer cells.内在适应 OXPHOS 输出能力和降低的肿瘤发生特性表现在多柔比星耐药的卵巢癌细胞中。
Biochim Biophys Acta Bioenerg. 2022 Nov 1;1863(8):148915. doi: 10.1016/j.bbabio.2022.148915. Epub 2022 Sep 2.
2
Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance.线粒体 ATP 为 ABC 转运蛋白介导的癌症化疗耐药性药物外排提供能量。
Nat Commun. 2021 May 14;12(1):2804. doi: 10.1038/s41467-021-23071-6.
3
Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.β-榄香烯对多柔比星耐药乳腺癌细胞内 d-荧光素钾盐(ABC 底物)转运动力学的影响及其相关分子机制。
Eur J Pharm Sci. 2018 Jul 30;120:20-29. doi: 10.1016/j.ejps.2018.04.037. Epub 2018 Apr 25.
4
ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.多柔比星耐药乳腺癌细胞中药物外排泵的 ATP 依赖性活性和线粒体定位。
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt A):1075-1084. doi: 10.1016/j.bbagen.2017.02.019. Epub 2017 Feb 16.
5
Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.刺猬信号通路通过靶向上皮性卵巢癌中的ABC转运蛋白ABCB1和ABCG2来调节药物敏感性。
Mol Carcinog. 2014 Aug;53(8):625-34. doi: 10.1002/mc.22015. Epub 2013 Feb 19.
6
Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.色瑞替尼(LDK378)对体外和体内ABCB1及ABCG2过表达细胞中化疗药物增强作用的影响。
Oncotarget. 2015 Dec 29;6(42):44643-59. doi: 10.18632/oncotarget.5989.
7
β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.β-胡萝卜素通过选择性调节人 P-糖蛋白功能逆转多药耐药癌细胞。
Phytomedicine. 2016 Mar 15;23(3):316-23. doi: 10.1016/j.phymed.2016.01.008. Epub 2016 Feb 6.
8
Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.FG020326通过与ABCB1结合并抑制其功能,使过表达ABCB1的细胞对化疗药物敏感。
Biochem Pharmacol. 2009 Aug 15;78(4):355-64. doi: 10.1016/j.bcp.2009.04.023. Epub 2009 May 3.
9
Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo.奈拉替尼在体外、体内和离体环境中逆转了 ABCB1 介导的化疗药物耐药性。
Mol Pharmacol. 2012 Jul;82(1):47-58. doi: 10.1124/mol.111.076299. Epub 2012 Apr 4.
10
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.拉帕替尼(泰立沙,GW572016)通过抑制ATP结合盒亚家族B成员1和G成员2的活性来逆转癌细胞中的多药耐药性。
Cancer Res. 2008 Oct 1;68(19):7905-14. doi: 10.1158/0008-5472.CAN-08-0499.

引用本文的文献

1
Cooperative Role of Carbonic Anhydrase IX/XII in Driving Tumor Invasion and Metastasis: A Novel Targeted Therapeutic Strategy.碳酸酐酶IX/ XII在驱动肿瘤侵袭和转移中的协同作用:一种新型靶向治疗策略
Cells. 2025 May 11;14(10):693. doi: 10.3390/cells14100693.
2
OXPHOS inhibition overcomes chemoresistance in triple negative breast cancer.氧化磷酸化抑制克服三阴性乳腺癌的化疗耐药性。
Redox Biol. 2025 Jun;83:103637. doi: 10.1016/j.redox.2025.103637. Epub 2025 Apr 15.
3
Ursodeoxycholic acid prompts glycolytic dominance, reductive stress and epithelial-to-mesenchymal transition in ovarian cancer cells through NRF2 activation.熊去氧胆酸通过激活NRF2促使卵巢癌细胞发生糖酵解优势、还原应激和上皮-间质转化。
Cell Death Discov. 2025 Apr 3;11(1):134. doi: 10.1038/s41420-025-02398-9.
4
Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFβ-ERK signaling.卵巢癌患者的无细胞腹水通过 TGFβ-ERK 信号诱导瓦博格代谢和细胞增殖。
Geroscience. 2024 Aug;46(4):3581-3597. doi: 10.1007/s11357-023-01056-1. Epub 2024 Jan 10.
5
High Fat Diet-Induced Obesity Dysregulates Splenic B Cell Mitochondrial Activity.高脂饮食诱导的肥胖症会扰乱脾脏 B 细胞的线粒体活性。
Nutrients. 2023 Nov 17;15(22):4807. doi: 10.3390/nu15224807.
6
Pan-tissue mitochondrial phenotyping reveals lower OXPHOS expression and function across cancer types.全组织线粒体表型分析揭示了不同癌症类型中氧化磷酸化表达和功能较低。
Sci Rep. 2023 Oct 5;13(1):16742. doi: 10.1038/s41598-023-43963-5.

本文引用的文献

1
Liquid chromatography method for simultaneous quantification of ATP and its degradation products compatible with both UV-Vis and mass spectrometry.适用于同时定量检测 ATP 及其降解产物的液相色谱方法,兼容紫外-可见吸收光谱法和质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Aug 15;1206:123351. doi: 10.1016/j.jchromb.2022.123351. Epub 2022 Jun 26.
2
Pyruvate Dehydrogenase Contributes to Drug Resistance of Lung Cancer Cells Through Epithelial Mesenchymal Transition.丙酮酸脱氢酶通过上皮-间质转化促进肺癌细胞的耐药性。
Front Cell Dev Biol. 2022 Jan 4;9:738916. doi: 10.3389/fcell.2021.738916. eCollection 2021.
3
Targeted disruption of mitochondria potently reverses multidrug resistance in cancer therapy.靶向破坏线粒体可有效逆转癌症治疗中的多药耐药性。
Br J Pharmacol. 2022 Jul;179(13):3346-3362. doi: 10.1111/bph.15801. Epub 2022 Feb 15.
4
Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia.鞘脂组成和线粒体生物能量学的改变代表了白血病多药耐药相关的协同治疗弱点。
FASEB J. 2022 Jan;36(1):e22094. doi: 10.1096/fj.202101194RRR.
5
Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma.线粒体可塑性促进人肝细胞癌对索拉非尼的耐药性及对STAT3抑制的易感性
Cancers (Basel). 2021 Nov 30;13(23):6029. doi: 10.3390/cancers13236029.
6
Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I.一种线粒体复合物I的泛醌非竞争性抑制剂对癌症的代谢靶向作用。
Cell Chem Biol. 2022 Mar 17;29(3):436-450.e15. doi: 10.1016/j.chembiol.2021.11.002. Epub 2021 Nov 30.
7
From OCR and ECAR to energy: Perspectives on the design and interpretation of bioenergetics studies.从 OCR 和 ECAR 到能量:生物能量学研究设计和解释的观点。
J Biol Chem. 2021 Oct;297(4):101140. doi: 10.1016/j.jbc.2021.101140. Epub 2021 Aug 28.
8
The impact of mitochondria on cancer treatment resistance.线粒体对癌症治疗耐药性的影响。
Cell Oncol (Dordr). 2021 Oct;44(5):983-995. doi: 10.1007/s13402-021-00623-y. Epub 2021 Jul 9.
9
Intrinsic OXPHOS limitations underlie cellular bioenergetics in leukemia.内在 OXPHOS 限制是白血病细胞生物能量学的基础。
Elife. 2021 Jun 16;10:e63104. doi: 10.7554/eLife.63104.
10
Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance.线粒体 ATP 为 ABC 转运蛋白介导的癌症化疗耐药性药物外排提供能量。
Nat Commun. 2021 May 14;12(1):2804. doi: 10.1038/s41467-021-23071-6.